Cellenkos Inc Receives US FDA Clearance for CK0802 Clinical Trial
MM Desk
7 May, 2026
Cellenkos Inc, a clinical-stage biotechnology company focused on regulatory T cell (Treg) therapies, has received
Cellenkos Inc, a clinical-stage biotechnology company focused on regulatory T cell (Treg) therapies, has received